Testicular shield for para-aortic radiotherapy and estimation of gonad doses

• Published in: Journal of medical physics Vol. 33; no. 4; pp. 158 - 161
• Main Authors: Ravichandran, R, Binukumar, J P, Kannadhasan, S, Shariff, M H, Ghamrawy, Kamal El
• Format: Journal Article
• Language: English
• Published: India Medknow Publications and Media Pvt. Ltd 01-10-2008; Medknow Publications & Media Pvt. Ltd; Medknow Publications; Wolters Kluwer Medknow Publications
• Subjects: Clinical dosimetry; gonadal shield; Health aspects; Methods; Original; para-aortic radiotherapy; Physiological aspects; Radiation therapy; Radiotherapy; stray radiations; Testis; India; gonadal shield; para-aortic radiotherapy; stray radiations; Clinical dosimetry
• ISSN: 0971-6203; 1998-3913
• DOI: 10.4103/0971-6203.44477

For radiotherapy of para-aortic and abdominal regions in male patients, gonads are to be protected to receive less than 2% of the prescribed dose. A testicular shield was fabricated for abdominal radiotherapy with 15 MV X-rays ((Clinac 2300 CD, Varian AG) with low melting point alloy (Cerroband). The dimensions of the testicular shield were 6.5 cm diameter and 3.5 cm depth with 1.5 cm wall thickness. During treatment, this shield was held in position by a rectangular sponge and Styrofoam support. Phantom measurement was carried out with a humanoid phantom and a 0.6 cc ion chamber. The mean energy of the scattered photon was calculated for single scattering at selected distances from the beam edge and with different field dimensions. One patient received radiotherapy with an inverted Y field and gonad doses were estimated using calibrated thermo-luminescent detector (TLD) chips. Measured doses with the ion chamber were 7.1 and 3.5% of the mid-plane doses without a shield at 3 and 7.5 cm off-field respectively. These values decreased to 4.6 and 1.7% with the bottom shield alone, and to 1.7 and 0.8% with both bottom and top shields covering the ion chamber. The measured doses at the gonads during the patient's treatment were 0.5-0.92% for the AP field (0.74 +/- 0.17%, n = 5) and 0.5-1.2% for the PA field (0.88 +/- 0.24%, n = 5). The dose received by the testis for the full course of treatment was 32 cGy (0.8%) for a total mid-plane dose of 40 Gy. The first-scatter energy estimated at the gonads is around 1.14 MeV for a primary beam of 15 MV for a long axis dimension of 37 cm of primary field. During the patient's treatment, the estimated absorbed doses at the gonads were comparable with reported values in similar treatments. The testicular shield reported in this study is of light weight and could be used conveniently in treatments of abdominal fields.